Cash and cash equivalents amounted to $69.8M as of September 30, compared to $32.5M as of December 31, 2024, a net increase of $37.4M. The company said, “The increase in Research tax credit during the three and the nine months ended September 30, 2025, is primarily due to the fact that more eligible activities have been carried out in the period, including the related costs of the FAREVA platform.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DBVT:
- DBV Technologies S.A. – American Depositary Shares (DBVT) Q3 Earnings Cheat Sheet
- Optimistic Outlook for DBV Technologies Amid Promising Viaskin Peanut Advancements
- DBV Technologies to sell $30M of ADSs through at-the-market program
- DBV Technologies Announces Board Member Resignation
- DBV Technologies Launches $150M ATM Equity Offering